Chemical and Pharmaceutical Bulletin · 2003 · 41 citations · 18 references
MedicineMedicinal ChemistryPharmacologyDrug DiscoveryNeuropharmacologyStructure-activity RelationshipsEnzyme InhibitionMonoamine NeurochemistryNeurochemical PharmacologySerotonergic PharmacologyLineweaver-burk PlotMonoamine MetabolismMonoamine Oxidase InhibitionMonoamine Oxidase InhibitorsMonoamine Oxidase InvolvementMonoamine OxidasesMonoamine Pharmacology
The inhibitory compound of monoamine oxidase (MAO) activity was isolated from the CH(2)Cl(2) fraction of the fructus of Evodia rutaecarpa and identified as 1-methyl-2-undecyl-4(1H)-quinolone (1). Compound 1 showed a selective inhibition of type B MAO (MAO-B) activity with the IC(50) value of 15.3 microM using a substrate kynuramine, but did not inhibit type A MAO (MAO-A) activity. The kinetic analysis using Lineweaver-Burk plots indicated that compound 1 competitively inhibited MAO-B activity with the K(i) value of 9.91 microM. The inhibition of MAO-B by compound 1 was found to be irreversible by dialysis of the incubation mixture. These results suggest that compound 1 is a potent irreversible inhibitor of MAO-B, and may regulate catecholamine content in the neurons.
18
A rapid microfluorimetric determination of monoamine oxidase
Michael Krajl · Biochemical Pharmacology · 1965 · 417 citations
Phenelzine vs Placebo in 50 Patients With Bulimia
B. Timothy Walsh · Archives of General Psychiatry · 1988 · 150 citations
Medicine, Pharmacology, Psychiatry +11